These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10214359)

  • 1. Malignant progression of rat Nb2 lymphoma cells: chromosomal alterations and metastatic properties.
    Too CK; Lee C; Sangster SM; Gout PW
    Cancer Genet Cytogenet; 1999 Apr; 110(2):115-23. PubMed ID: 10214359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rat Nb2 lymphoma: a novel model for tumor progression.
    Gout PW; Horsman DE; Fox K; De Jong G; Ma S; Bruchovsky N
    Anticancer Res; 1994; 14(6B):2485-92. PubMed ID: 7872671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Karyotypic changes associated with loss of prolactin dependency of rat Nb2 node lymphoma cell cultures.
    Horsman DE; Masui S; Gout PW
    Cancer Res; 1991 Jan; 51(1):282-7. PubMed ID: 1988090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbic acid recycling in Nb2 lymphoma cells: implications for tumor progression.
    Bode AM; Liang HQ; Green EH; Meyer TE; Buckley DJ; Norris A; Gout PW; Buckley AR
    Free Radic Biol Med; 1999 Jan; 26(1-2):136-47. PubMed ID: 9890649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of elongation factor-2, alpha4 phosphoprotein and Cdc5-like protein in prolactin-dependent/independent rat lymphoid cells.
    Too CK
    Mol Cell Endocrinol; 1997 Aug; 131(2):221-32. PubMed ID: 9296381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HRPAP20: a novel phosphoprotein that enhances growth and survival in hormone-responsive tumor cells.
    Karp CM; Pan H; Zhang M; Buckley DJ; Schuler LA; Buckley AR
    Cancer Res; 2004 Feb; 64(3):1016-25. PubMed ID: 14871833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin (PRL)-dependent expression of a zinc finger protein-encoding gene, Gfi-1, in Nb2 lymphoma cells: constitutive expression in autonomous sublines.
    Gilks CB; Porter SD; Barker C; Tsichlis PN; Gout PW
    Endocrinology; 1995 Apr; 136(4):1805-8. PubMed ID: 7895694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin induces expression of FGF-2 and a novel FGF-responsive NonO/p54nrb-related mRNA in rat lymphoma cells.
    Too CK; Knee R; Pinette AL; Li AW; Murphy PR
    Mol Cell Endocrinol; 1998 Feb; 137(2):187-95. PubMed ID: 9605521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.
    Buckley AR; Leff MA; Buckley DJ; Magnuson NS; de Jong G; Gout PW
    Cell Growth Differ; 1996 Dec; 7(12):1713-21. PubMed ID: 8959340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of G-proteins in the mitogenesis of rat lactogen-dependent and lactogen-independent Nb2 lymphoma cells.
    Too CK; Murphy PR; Friesen HG
    Endocrinology; 1990 Mar; 126(3):1368-73. PubMed ID: 2155099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells.
    Gout PW; Kang YJ; Buckley DJ; Bruchovsky N; Buckley AR
    Leukemia; 1997 Aug; 11(8):1329-37. PubMed ID: 9264389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin-Stimulated X-linked inhibitor of apoptosis protein expression during S phase cell cycle progression in rat Nb2 lymphoma cells.
    Krishnan N; Buckley DJ; Zhang M; Reed JC; Buckley AR
    Endocrine; 2001 Jul; 15(2):177-86. PubMed ID: 11720243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient requirement for prolactin as a growth initiator following treatment of autonomous Nb2 node rat lymphoma cell cultures with butyrate.
    Gout PW
    Cancer Res; 1987 Apr; 47(7):1751-5. PubMed ID: 3815371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor.
    Ali S; Pellegrini I; Kelly PA
    J Biol Chem; 1991 Oct; 266(30):20110-7. PubMed ID: 1718958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of specific fatty acids on prolactin-induced NB2 lymphoma cell proliferation.
    Sylvester PW; Ip MM; Briski KP
    Life Sci; 1993; 52(24):1977-84. PubMed ID: 8505862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A serum-free medium for culturing lactogen dependent and autonomous NB2 node lymphoma cells.
    Walker A; Croze F; Friesen HG
    Endocrinology; 1987 Jun; 120(6):2389-97. PubMed ID: 3552636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP; Buckley DJ; Buckley AR
    Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and nuclear localization of a novel prolactin and cytokine-responsive carboxypeptidase D.
    Too CK; Vickaryous N; Boudreau RT; Sangster SM
    Endocrinology; 2001 Mar; 142(3):1357-67. PubMed ID: 11181555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells.
    Dodd F; Limoges M; Boudreau RT; Rowden G; Murphy PR; Too CK
    J Cell Biochem; 2000 Apr; 77(4):624-34. PubMed ID: 10771518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin-induced proliferation of the Nb2 T-lymphoma is associated with protein kinase-C-independent phosphorylation of stathmin.
    Meyer N; Prentice DA; Fox MT; Hughes JP
    Endocrinology; 1992 Oct; 131(4):1977-84. PubMed ID: 1396341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.